WSFS
CATX icon

Wilmington Savings Fund Society’s Perspective Therapeutics CATX Stock Holding History

Wilmington Savings Fund Society’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-83
Closed -$1.11K – 2103
2024
Q3 		$1.11K Buy
+83
New +$1.1K ﹤0.01% 1978

Other funds holding CATX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
NWMG
Nicholson Wealth Management Group Charlestown, South Carolina $172M AUM 10.38% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Wilmington Savings Fund Society's CATX Position: Q4 2024 in Review

Wilmington Savings Fund Society sold out of Perspective Therapeutics (CATX) in Q4 2024, closing a stake of 83 shares — an estimated $1.11K sold.

Wilmington Savings Fund Society first reported a position in CATX in Q3 2024 and held it in 1 quarter. The position peaked at $1.11K in Q3 2024. 135 funds tracked by Wall St. Rank hold CATX as of Q4 2024.

  • Wilmington Savings Fund Society reported no remaining Perspective Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Wilmington Savings Fund Society sold 83 Perspective Therapeutics shares in Q4 2024, an estimated $1.11K.
  • Wilmington Savings Fund Society first reported a position in Perspective Therapeutics in Q3 2024 and held it in 1 quarter.
  • Wilmington Savings Fund Society's Perspective Therapeutics position peaked at $1.11K in Q3 2024.
  • 135 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q4 2024.

Based on Wilmington Savings Fund Society's 13F filing for Q4 2024, filed 28 Jan 2025.